0000880771-16-000179.txt : 20160816 0000880771-16-000179.hdr.sgml : 20160816 20160816173419 ACCESSION NUMBER: 0000880771-16-000179 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160812 FILED AS OF DATE: 20160816 DATE AS OF CHANGE: 20160816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Low Raymond Anthony CENTRAL INDEX KEY: 0001391388 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 161836961 MAIL ADDRESS: STREET 1: 25 SHADOW TREE CT CITY: DANVILLE STATE: CA ZIP: 94506 4 1 certent-form4.xml PRIMARY DOCUMENT X0306 4 2016-08-12 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001391388 Low Raymond Anthony 950 TOWER ROAD, SUITE 900 FOSTER CITY CA 94404 0 1 0 0 VP, Finance & Controller Common Stock 2016-08-12 4 M 0 1250 0 A 10908 D Restricted Stock Unit 2016-08-12 4 A 0 10000 0 A Common Stock 10000 20000 D Restricted Stock Unit 2016-08-12 4 M 0 1250 0 D Common Stock 1250 18750 D Includes 9,658 shares purchased under the Issuer's Employee Stock Purchase Plan from February 28, 2014 through May 31, 2016. Granted under the Issuer's 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of SciClone Pharmaceuticals, Inc.'s common stock. Each RSU will vest and be settled on August 15, 2017, subject to the reporting person's continued employment, but will terminate upon the occurrence of a change in control on or before March 31, 2017. Granted under the Issuer's 2005 Equity Incentive Plan. Vesting for such RSUs will occur 25% on March 16, 2016, 25% on March 16, 2017, 25% on March 16, 2018, and 25% on March 16, 2019, or on such later date thereafter as the Company's trading window opens, if it is not open on any of such dates, contingent upon the executive's continued employment. /s/ Friedhelm Blobel, Attorney-in-Fact For Raymond A. Low 2016-08-16